"Somos una institución de salud del sector privado que presta sus servicios a la comunidad desde 1993 con conceptos innovadores y de cambios radicales en la forma de prestar los servicios de salud basados en principios éticos, humanos y tecnológicos, contando para ello con un equipo multidisciplinario de profesionales dispuestos a ofrecer un servicio de confianza, oportuno y personalizado. La confianza y la experiencia se elaboran con el tiempo y son el cimiento de la relación que se inició en 1997 entre el CENTRO MEDICO MONTE CARMELO y diversas empresas, sustentada en la base del respeto por la ética profesional y en el cumplimiento de las responsabilidades mutuamente adquiridas."

During the past decade, Centro Medico Monte Carmelo conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 7 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 5 clinical trials were completed. i.e. 250% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Centro Medico Monte Carmelo" #1 collaborator was "German Breast Group" with 1 trials as a collaborator and "NSABP Foundation Inc" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Centro Medico Monte Carmelo" are "Breast Cancer" (2 trials), "Atrial Fibrillation" (1 trials), "Breast Neoplasms" (1 trials), "Carcinoma, Non-Small-Cell Lung" (1 trials) and "Estrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer" (1 trials). Many other conditions were trialed in "Centro Medico Monte Carmelo" in a lesser frequency.

Most popular intervention types in "Centro Medico Monte Carmelo" are "Drug" (10 trials). Other intervention types were less common.

The name of intervention was led by "Paclitaxel" (4 trials), "Placebo" (3 trials), "Atezolizumab" (2 trials), "Carboplatin" (2 trials) and "Ipatasertib" (2 trials). Other intervention names were less common.

The vast majority of trials in "Centro Medico Monte Carmelo" are 11 trials for "All" genders.

Currently, there are NaN active trials in "Centro Medico Monte Carmelo". undefined are not yet recruiting, undefined are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Centro Medico Monte Carmelo, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Centro Medico Monte Carmelo, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".